Keywords: actelion, tracleer, approved, uk, ireland, reduction, new

Actelion

Article | 05 May 2008

Print This

Swiss drugmaker Actelion's Tracleer (bosentan), a dual endothelin receptor antagonist, has been approved in the UK and Ireland for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in